ClinicalTrials.gov
ClinicalTrials.gov Menu

Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02443675
Recruitment Status : Active, not recruiting
First Posted : May 14, 2015
Last Update Posted : May 14, 2015
Sponsor:
Information provided by (Responsible Party):
Cure Cancer Worldwide, LLC

Brief Summary:
Observational Study of Pain Reduction in Late Stage Cancer Patients Receiving Low-Dose Chemotherapy

Condition or disease
Acute Pain

Detailed Description:
Observational Study of Pain Reduction in Late Stage Cancer Patients who are Receiving Low-Dose Chemotherapy (Metabolic Targeting)

Study Type : Observational
Estimated Enrollment : 300 participants
Official Title: Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy
Study Start Date : May 2015
Estimated Primary Completion Date : August 2020
Estimated Study Completion Date : December 2020



Primary Outcome Measures :
  1. Pain Level Self Assessment [ Time Frame: 5 years ]
    From enrollment in study to termination of study (August 2020)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients Receiving Low Dose Chemotherapy
Criteria

Inclusion Criteria:

  • Patient requests to be included in this study

Exclusion Criteria:

  • Patient does not request to be included in this study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02443675


Sponsors and Collaborators
Cure Cancer Worldwide, LLC
Investigators
Study Director: gary l smith, mba Cure Cancer Worldwide, LLC

Responsible Party: Cure Cancer Worldwide, LLC
ClinicalTrials.gov Identifier: NCT02443675     History of Changes
Other Study ID Numbers: C4 OS-1
First Posted: May 14, 2015    Key Record Dates
Last Update Posted: May 14, 2015
Last Verified: May 2015

Additional relevant MeSH terms:
Acute Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms